Background: Fibrinogen levels are reported to be elevated in hypertensive patients and tend to cluster with nearly all other established cardiovascular risk factors. The aim of this study was to evaluate the relationship between plasma fibrinogen and a number of other cardiovascular risk factors in patients with essential hypertension.
Methods: We studied 118 men with essential hypertension, aged 18–65 years. The clinical evaluation included measurements of blood pressure (mercury sphygmomanometer, Korotkoff I and V), levels of plasma fibrinogen, total cholesterol, high-density-lipoprotein (HDL) cholesterol, triglycerides and blood glucose and the ratio of total-cholesterol to HDL-cholesterol levels; a detailed history of medical and personal habits was also recorded.
Results: As expected, plasma fibrinogen levels were significantly higher in smokers than in non-smokers, with the number of cigarettes smoked correlating postively with the fibrinogen level. Patients with a total-cholesterol level in excess of 220mg/dl had significantly higher fibrinogen levels, and both univariate and multivariate analyses showed total-cholesterol and fibrinogen levels to be positively correlated. A weaker but significant relationship was noted between the fibrinogen level and triglyceride levels (P = 0.001 7) and between the fibrinogen level and the ratio of total-cholesterol to HDL-cholesterol levels (P = 0.0006). Fibrinogen levels were not significantly associated with either systolic or diastolic blood pressures.
Conclusion: A family history of hypertension appears to potentiate the tendency of fibrinogen to cluster with other cardiovascular risk factors in hypertensive patients.
MeadeTWChakrabartiRHainesAPNorthWRSStirlingYThompsonSG: Haemostatic function and cardiovascular deaths: Early results of a prospective study. Lancet1980, i:1050–1053.
2.
WilhelmsenLSvardsuddKKorsan-BengstenKLarssonBTibblingG: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med1984, 311:501–505.
3.
StoneMCThorpJM: Plasma fibrinogen: A major coronary risk factor. J R Coll Gen Pract1985, 35:565–569.
4.
MeadeTWMellowsSBrozovicMMillerGJChakrabartiRNorthWR: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet1986, ii:533–537.
5.
KannelWBWolfPACastelliWPD'AgostinoRB: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA1987, 258:1183–1186.
6.
LeeAJSmithWCSLoweGDOTunstall-PedoeH: Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study. J Clin Epidemiol1990, 43:913–919.
7.
QuizilbashNJonesLWarlowCMannJ: Fibrinogen and lipid concentrations as risk factors for transient ischemic attacks and minor ischemic strokes. BMJ1991, 303:605–609.
8.
YarnellJWBakerIASweetnamPMBaintonDOBrienJRWhiteheadPJ: Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation1991, 83:836–844.
9.
KannelWB: Fibrinogen: A major cardiovascular risk factor. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell-MZV, 1992: 101–109.
10.
FolsomARConlanMG: Fibrinogen and cardiovascular risk in the Atherosclerosis Risk In Communities (ARIC) Study. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell-MZV, 1992: 124–129.
11.
ReschKLErnstEMatraiAPaulsenHF: Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med1992, 117:371–375.
12.
ErnstEReschKL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med1993, 118:956–963.
13.
SadoshimaSTanakaK: Fibrinogen and low-density lipoproteins in the development of cerebral atherosclerosis. Atherosclerosis1979, 34:93–98.
14.
SmithECrosbieL: Fibrinogen and fibrin in atherogenesis. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell-MZV, 1992: 4–10.
15.
ThompsonWDStirkCMSmithEB: Fibrin degradation products as the pathological growth stimulus to atherosclerotic plaque formation. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell-MZV, 1992: 35–37.
16.
BiniAKudrykBJ: Fibrinogen, fibrin and atherosclerosis: Vascular and systemic effects. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell–MZV, 1992: 41–45.
17.
LoweGDODrummondMMThirdJHBremerWF: Increased plasma fibrinogen and platelet aggregates in type II hyperlipoproteinemia. Thromb Haemost1979, 42:1503–1507.
18.
LandolfiRDe CristoforoRDe CandiaERocaBBizziB: Effect of fibrinogen concentration on the velocity of platelet aggregation. Blood1991, 78:377–382.
BelchJJFMcArdleBMPurnsPLoweGDOForbesCD: The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost1984, 51:6–8.
21.
DotevallAKuttiJTeger-NilssonACWadenvikHWilhelmsenL: Platelet reactivity, fibrinogen and smoking. Eur J Haematol1987, 38:55–59.
22.
MeadeTWImersonJStirlingY: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease. Lancet1987, ii:986–988.
23.
KannelWBD'AgostinoRBBelangerAJ: Fibrinogen, smoking and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J1987, 113:1006–1010.
24.
FitzgeraldGAOatesJANowakJ: Cigarette smoking and haemostatic function. Am Heart J1988, 115:267–270.
25.
RosengrenAWilhelmsenLWelinLTsipogianniATeger-NilssonACWedelH: Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ1990, 300:634–638.
26.
MollerLKristensenTSJespersenJ: Association between plasma fibrinogen and coronary heart disease risk factors in a Danish Cohort. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell–MZV, 1992: 134–140.
27.
KoenigWSundMErnstEStieberJMrazWHombachV: Plasma viscosity and cardiovascular risk factors. Results from the MONICA Project, Augsburg. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell–MZV, 1992: 141–145.
28.
FogariRZoppiATettamantiFMalamaniGDMarasiGVanasiaA: Plasma fibrinogen in normotensive and hypertensive subjects. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell–MZV, 1992: 278–281.
29.
VyssoulisGPKarpanouEAggeliDToutouzaMPitsavosCCToutouzasP: Plasma fibrinogen values in arterial hypertension. Effect of risk factor clustering. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell–MZV, 1992: 282–286.
30.
HenseHWKrobotKEberleEKeilUCremerP: Lipoproteins and fibrinogen in the general population. Results from the MONICA Augsburg Survey 1989/90. In Fibrinogen. A ‘New’ Cardiovascular Risk Factor. Edited by ErnstEKoenigWLoweGDOMeadeTW.Vienna: Blackwell–MZV, 1992:146–149.
31.
StokesKannel WBWolfPAKupplesLAD'AgostinoRB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation1987, 75 (suppl 5):65–73.
32.
ClaussA: Rapid physiological coagulation method for the determination of fibrinogen [in German]. Acta Haematol1957, 17:237–246.
33.
RoschlauP: Enzymatic evaluation of total cholesterol in serum [in German]. Z Klin Chem Klin Biochem1974, 12: 403–407.
34.
ViikariJ: Precipitation of plasma lipoprotein by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest1976, 86: 265–269.
35.
SAS Institute: SAS User's Guide: Statistics. Cary, North Carolina: SAS Institute; 1982.
36.
BalleisenLAssmannGBaileyJEppingPHSchulteHVan De LooJ: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. II. Baseline data on the relationship with blood pressure, blood glucose, uric acid and lipid fraction. Thromb Haemost1985, 54: 721–723.
37.
HeinrichJSandkampMKorottRSchulteHAssmannG: Relationship of lipoproteins to variables of coagulation and fibrinolysis in a healthy population. Clin Chem1991, 37: 1950–1954.
38.
Anonymous: Haemostatic factors and coronary heart disease. Lancet1981, i:22–23.
39.
LetcherRLChienSPickeringTGSealeyJLaraghJH: Direct relationship between blood pressure and blood viscosity in normal and hypertensive patients: Role of fibrinogen and concentration. Am J Med1981, 70: 1195–1202.
